Xover or parallel? [Power / Sample Size]

posted by jag009  – NJ, 2013-06-03 19:51 (4348 d 00:35 ago) – Posting: # 10716
Views: 7,858

Hi Helmut,

❝ Maybe I’m misinterpreting the abstract (I don’t have the article):

“Subjects were randomized to receive a single dose of 30, 60, or 90 mg of duloxetine.”

Smelled of cross-over to me. But your interpretation (parallel) is valid as well.

@BK: which design?


This gave me the idea that it was a PK evaluation study.

"The 10 subjects who received the 30-mg dose in the single-dose phase continued on to the multiple-dose phase and received 30 mg of duloxetine twice daily for 7 days."

I guess they randomized the subject to determine who would receive the 30/60/90 mg dose?

John

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
26 visitors (0 registered, 26 guests [including 20 identified bots]).
Forum time: 20:26 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5